GENO.STGENO.STSTO
Loading
EBITDA Margin Over TimeContracting
Percentile Rank71
3Y CAGR+21.1%
5Y CAGR+13.0%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+21.1%/yr
vs +24.7%/yr prior
5Y CAGR
+13.0%/yr
Recent acceleration
Acceleration
-3.6pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM25.86%-40.0%
202443.10%+2.0%
202342.24%+190.1%
202214.56%-53.1%
202131.05%+121.0%
202014.05%-50.0%
201928.11%+367.5%
20186.01%+122.1%
2017-27.23%+62.5%
2016-72.68%-